CA
NZ
UK
AU
IND
US
YS Management Company Limited and Yif Liu filed Amendment No. 3 to their Schedule 13D with the SEC on November 12, 2026, disclosing a reduced beneficial ownership percentage in AIFU Inc. following the company's issuance of new Class A ordinary shares on November 6, …
Canton Strategic Holdings, Inc. filed an 8-K press release on November 12, 2026, sharing comments on Maximum Extractable Value ("MEV") in onchain transactions and its potential impact on market structure for tokenized assets.
Sidus Space, Inc. (NASDAQ:SIDU) announced on November 12, 2026, that registered patent attorney and Widerman Malek, PL co-founder Mark R. Malek was appointed to its Board of Directors, effective November 11, 2026, becoming the third director added since October.
Silence Therapeutics plc filed a Current Report on Form 8-K on November 12, 2026, furnishing a press release with its financial and business results for the third quarter ended September 30, 2026, alongside an update on a definitive acquisition agreement with Merck KGaA, Darmstadt, …
The Bank of Nova Scotia filed a free writing prospectus on November 11, 2026, disclosing the terms of Contingent Income Auto-Callable Securities with Memory Coupon linked to the common stock of Micron Technology, Inc., with a pricing date of November 16, 2026, and a …
Data443 Risk Mitigation, Inc. filed a Form 8-K current report on November 12, 2026, disclosing via Regulation FD that its enterprise AI collaboration platform, Convaa.ai, is now available on the App Store and works with iPhone Duo.
Filana Therapeutics, Inc. filed a Form 8-K on November 12, 2026, disclosing the appointment of Jill M. Quigley to its Board of Directors, effective November 8, 2026.
VisionWave Holdings, Inc. filed a Form 8-K on November 12, 2026, disclosing that it entered into a non-binding Letter of Intent on November 9, 2026, to acquire a 51% participatory interest in EUROPOSTACHSERVICE LLC, a Ukrainian unmanned aerial systems company, for $7,000,000 in cash.
GT Biopharma, Inc. filed a Form 8-K on November 12, 2026, reporting the results of a Special Meeting of Stockholders held on November 11, 2026, at which four proposals were submitted to a vote.
Clarivate Plc filed a Form 8-K on November 12, 2026, announcing the expiration and results of cash tender offers by its wholly-owned subsidiary, Clarivate Science Holdings Corporation, for certain of its debt securities.
Please wait processing your request...